- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
CinCor Pharma (NASDAQ:CINC), Quotes and News Summary
CinCor Pharma (NASDAQ: CINC)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.560 | -0.0600 | ||||
| REV | 0 |
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.500 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
CinCor Pharma Questions & Answers
You can purchase shares of CinCor Pharma (NASDAQ: CINC) through any online brokerage.
Other companies in CinCor Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), Reata Pharmaceuticals (NASDAQ:RETA) and Supernus Pharmaceuticals (NASDAQ:SUPN).
The latest price target for CinCor Pharma (NASDAQ: CINC) was reported by Oppenheimer on Thursday, July 21, 2022. The analyst firm set a price target for 35.00 expecting CINC to fall to within 12 months (a possible 0.00% downside). 6 analyst firms have reported ratings in the last year.
The stock price for CinCor Pharma (NASDAQ: CINC) is $35 last updated Today at August 8, 2022, 3:58 PM UTC.
There are no upcoming dividends for CinCor Pharma.
CinCor Pharma’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for CinCor Pharma.
CinCor Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.